Santes® and Ialos®
Product description
Innovative solutions for vaginal and bladder/urogenital disorders.
Five clinical trials and one systemic review confirm safety and efficacy of Santes in various forms of vaginal atrophy, including efficacy in the prevention of acute side effects of radiotherapy after cervical surgery.
Three clinical studies demonstrate efficacy of Ialos in improving vaginal epithelium integrity and reducing itching and dyspreunia in postmenopausal women with vaginal atrophy. One of these studies was conducted using combined therapy with Santes. Two additional trials prove efficacy in preventing and reducing radiotherapy-induced symptoms of cystitis.
Read more
Five clinical trials and one systemic review confirm safety and efficacy of Santes in various forms of vaginal atrophy, including efficacy in the prevention of acute side effects of radiotherapy after cervical surgery.
Three clinical studies demonstrate efficacy of Ialos in improving vaginal epithelium integrity and reducing itching and dyspreunia in postmenopausal women with vaginal atrophy. One of these studies was conducted using combined therapy with Santes. Two additional trials prove efficacy in preventing and reducing radiotherapy-induced symptoms of cystitis.
Specifications
| Categories | Food Supplements / Nutraceuticals |
|---|---|
| Sales markets | Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America |
| Supplied from | Italy |
| Product Applications | Dietary Supplements; Food Supplements |
| Product Certifications | Quality assurance |
More products from LO.LI. PHARMA INTERNATIONAL S.R.L.
Santes® and Ialos®
